Bill & Melinda Gates Foundation Immunocore Holdings PLC Transaction History

Bill & Melinda Gates Foundation

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Nov 15, 2021	SELL	$32.22 - $41.5 $33.9 Million - $43.7 Million	-1,053,225 Reduced 64.61%	576,923 $23 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $41.5 $33.9 Million - $43.7 Million	1,053,225 Added 182.56%	1,630,148 $64 Million
Q1 2021 Nov 15, 2021	SELL	$36.3 - $56.34 $38.2 Million - $59.3 Million	-1,053,225 Reduced 64.61%	576,923 $24.6 Million
Q1 2021 May 14, 2021	BUY	$36.3 - $56.34 $59.2 Million - $91.8 Million	1,630,148 New	1,630,148 $69.4 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Bill & Melinda Gates Foundation, based on Form 13F filings with the SEC.

Stay updated on Bill & Melinda Gates Foundation with notifications on news.